Xin Du

机构：Chinese Center For Disease Control and Prevention, Shenzhen Second People's Hospital · ORCID：0000-0002-5497-2783

发表论文 14 篇 · 总被引 26 次 · h-index 3

代表论文

• Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa‐2b (2024 · British Journal of Haematology · 被引 17)
• Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera (2025 · Blood Advances · 被引 3)
• Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025) (2025 · Blood Science · 被引 3)
• Efficacy and Safety of an Engineered, Liver-Tropic Adeno-Associated Virus Vector Expressing Factor IX Padua Administered with Prophylactic Glucocorticoids in Patients with Hemophilia B: A Multi-Center, Single-Arm, Phase 3 Trial (2024 · Blood · 被引 2)
• A Specific Coagulation Factor X Activator for on-Demand Treatment in Hemophilia with Inhibitors (2024 · Blood · 被引 1)
• The underdiagnosis of pulmonary tuberculosis in non-TB-designated health facilities in China: a nationwide retrospective study (2025 · BMC Infectious Diseases)